Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C032904 |
2,2',3,5',6-pentachlorobiphenyl |
2,2',3,5',6-pentachlorobiphenyl results in increased activity of RYR1 protein | increases activity | 16411661
|
C010498 |
2,3,6,2',3',6'-hexachlorobiphenyl |
2,3,6,2',3',6'-hexachlorobiphenyl results in increased activity of RYR1 protein | increases activity | 16411661
|
C009828 |
2,4,5,2',5'-pentachlorobiphenyl |
2,4,5,2',5'-pentachlorobiphenyl results in increased activity of RYR1 protein | increases activity | 16411661
|
C009407 |
2,5,2',5'-tetrachlorobiphenyl |
2,5,2',5'-tetrachlorobiphenyl results in increased activity of RYR1 protein | increases activity | 16411661
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of RYR1 mRNA | affects expression | 17562736
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of RYR1 mRNA | affects expression | 16483693
|
D002110 |
Caffeine |
Caffeine results in increased activity of RYR1 protein | increases activity | 16484216
|
D002110 |
Caffeine |
TRPC3 protein affects the reaction [Caffeine results in increased activity of RYR1 protein] | affects reaction|increases activity | 16484216
|
D002118 |
Calcium |
Calcium affects the folding of [CALM1 protein binds to RYR1 protein modified form] | affects binding|affects folding | 15381065
|
D002118 |
Calcium |
Calcium affects the reaction [CALM1 protein binds to and affects the activity of RYR1 protein] | affects activity|affects binding|affects reaction | 15381065
|
D002118 |
Calcium |
Calcium affects the reaction [CALM1 protein binds to and affects the activity of RYR1 protein] | affects activity|affects binding|affects reaction | 15628869
|
D002118 |
Calcium |
Calcium affects the reaction [CALM1 protein modified form binds to and affects the activity of RYR1 protein] | affects activity|affects binding|affects reaction | 15628869
|
D002118 |
Calcium |
Calcium results in increased activity of RYR1 protein | increases activity | 15326217
|
C073316 |
carvacrol |
carvacrol results in increased activity of RYR1 protein | increases activity | 17641978
|
D020111 |
Chlorodiphenyl (54% Chlorine) |
Chlorodiphenyl (54% Chlorine) results in increased expression of RYR1 protein | increases expression | 16309888
|
C023036 |
perfluorooctanoic acid |
perfluorooctanoic acid results in decreased expression of RYR1 mRNA | decreases expression | 16221955
|
D020849 |
Raloxifene |
Raloxifene affects the expression of RYR1 mRNA | affects expression | 14699072
|
D012430 |
Ruthenium Red |
Ruthenium Red results in decreased activity of RYR1 protein | decreases activity | 15326217
|
D012433 |
Ryanodine |
Triclosan promotes the reaction [Ryanodine binds to RYR1 protein] | affects binding|increases reaction | 18795164
|
D012433 |
Ryanodine |
Ryanodine results in decreased activity of RYR1 protein | decreases activity | 15326217
|
D012433 |
Ryanodine |
Ryanodine results in increased activity of RYR1 protein | increases activity | 15326217
|
D020123 |
Sirolimus |
Sirolimus inhibits the reaction [FKBP1A protein binds to RYR1 protein] | affects binding|decreases reaction | 16411661
|
D016559 |
Tacrolimus |
Tacrolimus inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of RYR1 protein] | decreases reaction|increases expression | 18172886
|
D016559 |
Tacrolimus |
Tacrolimus inhibits the reaction [FKBP1A protein binds to RYR1 protein] | affects binding|decreases reaction | 16411661
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of RYR1 mRNA | affects expression | 14699072
|
C020806 |
tetrabromobisphenol A |
tetrabromobisphenol A results in increased activity of RYR1 protein | increases activity | 18329244
|
C020806 |
tetrabromobisphenol A |
Tetracaine inhibits the reaction [tetrabromobisphenol A results in increased activity of RYR1 protein] | decreases reaction|increases activity | 18329244
|
D013748 |
Tetracaine |
Tetracaine inhibits the reaction [tetrabromobisphenol A results in increased activity of RYR1 protein] | decreases reaction|increases activity | 18329244
|
D013749 |
Tetrachlorodibenzodioxin |
Tacrolimus inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of RYR1 protein] | decreases reaction|increases expression | 18172886
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of RYR1 protein | increases expression | 18172886
|
D013943 |
Thymol |
Thymol results in increased activity of RYR1 protein | increases activity | 17641978
|
D014260 |
Triclosan |
Triclosan promotes the reaction [Ryanodine binds to RYR1 protein] | affects binding|increases reaction | 18795164
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.42 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.72 | 11752688 15322242 14514962 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.43 | 18287403 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.25 | 16835633 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
4.47 | 17451421 17308373 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
2.51 | 15800139 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.83 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.71 | 10982225 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
2.29 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Sirolimus |
2.29 | 21115397 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
2.92 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.66 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.68 | 15746008 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
4.34 | 16580743 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
1.88 | 16912660 17242785 16837676 15758505 15572757 17440819 17893378 15775269 17595753 17952589 17049068 17261762 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
1.88 | 18984771 19011961 17049068 20544844 19066611 19200415 19142967 11161223 17440819 15668708 19244106 19084267 16818667 18629630 19103187 19221464 18997820 20859285 18425577 15565566 21138602 16873071 20065188 18815881 17261762 19155303 20005174 19189212 16273361 19189210 18821012 20135344 18351453 17893378 20390343 21152245 18855134 19115204 19410462 19288272 17242785 19487384 19059307 19289846 16202921 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.88 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.69 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.38 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
4.59 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Sirolimus |
4.59 | 19335982 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
4.59 | 16924424 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Sirolimus |
3.53 | 19435901 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
9.11 | 17572228 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
9.11 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.30 | 18850075 16120746 18670907 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
7.68 | 15775269 |
MESH:D002318 |
Cardiovascular Diseases |
|
Tacrolimus |
7.68 | 17703430 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.51 | 10977129 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.05 | 16835633 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.05 | 16354765 15668235 8697196 15340226 12621046 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
4.49 | 15800139 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
9.17 | 14669216 17141729 |
MESH:D000013 |
Congenital Abnormalities |
|
Triclosan |
9.17 | 19283420 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.25 | 10048152 15322242 20055451 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.23 | 19031437 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
4.05 | 17474826 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.64 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
8.66 | 17451421 15920148 17308373 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
8.66 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
6.02 | 12392966 16227642 11529661 18071297 19370779 18713872 12540782 19416960 11739529 12705907 19420014 14725611 16109766 11461765 16177239 19739265 11743745 10663392 16393943 17906064 10774834 12153990 17562736 16781746 14986274 17522070 16081117 11421492 15619225 12958197 14550746 11834606 16485898 10915739 19164858 11287661 2444490 19085960 12594235 15968718 19923254 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Chlorodiphenyl (54% Chlorine) |
6.02 | 17851650 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.02 | 20420201 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.97 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.66 | 11462148 |
MESH:D004381 |
Duodenal Ulcer |
|
Tacrolimus |
5.01 | 17202747 |
MESH:D004487 |
Edema |
|
perfluorooctanoic acid |
10.88 | 12083418 17259670 |
MESH:D004487 |
Edema |
|
Raloxifene |
10.88 | 15860553 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
10.88 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.77 | 18230668 15322242 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
8.82 | 15845917 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
8.82 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
2.96 | 17893378 16202921 20544844 19155303 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.91 | 10568697 9294722 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.91 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
7.59 | 17473493 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
7.59 | 19224547 14986274 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.16 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.33 | 11858732 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.40 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.05 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
2.82 | 20067830 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.55 | 16983495 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.47 | 10696789 |
MESH:D006086 |
Graft vs Host Disease |
|
Tacrolimus |
5.75 | 16376943 |
MESH:D006130 |
Growth Disorders |
|
Tacrolimus |
4.83 | 11041285 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Sirolimus |
4.37 | 19435901 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.26 | 10048152 11294989 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
3.44 | 11110106 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.21 | 11000095 |
MESH:D006505 |
Hepatitis |
|
Caffeine |
4.85 | 11394713 |
MESH:D006529 |
Hepatomegaly |
|
perfluorooctanoic acid |
8.23 | 3609246 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.23 | 15340226 16120746 12621046 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.92 | 16354765 15340226 16959395 8697196 18606429 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
7.51 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
perfluorooctanoic acid |
7.51 | 12083418 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
5.06 | 17577099 15787275 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.06 | 18670907 18850075 |
MESH:D006984 |
Hypertrophy |
|
Sirolimus |
5.11 | 19211884 |
MESH:C537153 |
Hypomagnesemia primary |
|
Tacrolimus |
6.02 | 11041285 |
MESH:D007022 |
Hypotension |
|
Tacrolimus |
4.99 | 11041285 |
MESH:D007248 |
Infertility, Male |
|
Triclosan |
4.33 | 20821571 |
MESH:D007249 |
Inflammation |
|
perfluorooctanoic acid |
11.49 | 12083418 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
11.49 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
11.49 | 12200463 12878042 |
MESH:D007249 |
Inflammation |
|
Triclosan |
11.49 | 9584910 20507366 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.21 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
6.26 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
Tacrolimus |
6.26 | 11041285 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
2.94 | 18625569 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Calcium |
4.92 | 16316344 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.37 | 16973256 |
MESH:D007984 |
Leydig Cell Tumor |
|
perfluorooctanoic acid |
5.10 | 8812269 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.06 | 17567588 15342952 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Sirolimus |
3.53 | 17050028 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
3.53 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.53 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.60 | 19784758 12969438 12587719 16611625 16610002 19460945 11587558 19014921 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.12 | 16871587 17185352 |
MESH:D008113 |
Liver Neoplasms |
|
perfluorooctanoic acid |
7.19 | 18709148 14757943 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
7.19 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.19 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.03 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
2.21 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.21 | 11884234 19555203 |
MESH:D008305 |
Malignant Hyperthermia |
marker/mechanism |
|
| 14708096 14570802 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.63 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
6.30 | 11731420 16827153 14580682 19196722 19196723 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Triclosan |
6.30 | 15358634 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.42 | 19453300 |
MESH:D008545 |
Melanoma |
|
Sirolimus |
3.68 | 19282848 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
3.68 | 12393984 19393235 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.05 | 15990972 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.44 | 19513568 |
OMIM:255320 |
MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA |
marker/mechanism |
|
| |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.43 | 15863610 |
MESH:D009062 |
Mouth Neoplasms |
|
Sirolimus |
4.60 | 19435901 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
3.35 | 16497877 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.91 | 12213967 |
MESH:D020512 |
Myopathy, Central Core |
marker/mechanism |
|
| 14708096 14570802 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
5.43 | 16343187 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.49 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.47 | 19410462 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.87 | 19196722 19189210 19200415 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.09 | 14600291 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
8.41 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Tacrolimus |
8.41 | 15081597 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
perfluorooctanoic acid |
4.82 | 9802331 |
MESH:D010024 |
Osteoporosis |
|
Calcium |
7.26 | 17882678 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
7.26 | 15775268 17882678 19059307 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
4.10 | 17893378 15579764 15758505 17823083 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.29 | 16870215 |
MESH:D010300 |
Parkinson Disease |
|
Sirolimus |
3.69 | 19682553 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.12 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.43 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
perfluorooctanoic acid |
9.23 | 17132714 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.23 | 11896295 11399792 11222880 11118676 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
3.41 | 15731164 16536755 16220300 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
3.41 | 15067354 |
MESH:D011693 |
Purpura |
|
Raloxifene |
5.43 | 15770314 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.71 | 18990726 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
1.98 | 16192470 |
MESH:D012893 |
Sleep Disorders |
|
Caffeine |
5.18 | 19395429 |
MESH:D007319 |
Sleep Initiation and Maintenance Disorders |
|
Caffeine |
4.97 | 17225163 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
4.16 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.91 | 19457130 |
MESH:D020521 |
Stroke |
|
Raloxifene |
3.72 | 16837676 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
12.07 | 12697716 |
MESH:D013959 |
Thyroid Diseases |
|
Triclosan |
12.07 | 19910387 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
5.08 | 19048282 |
MESH:D014402 |
Tuberous Sclerosis |
|
Sirolimus |
5.44 | 18495876 21115397 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
5.06 | 17572228 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
5.06 | 16712894 8653321 17572228 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.85 | 10982225 |
MESH:D014605 |
Uveitis |
|
Sirolimus |
5.50 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.47 | 12125929 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
5.08 | 16837676 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.43 | 16343187 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.12 | 15886252 |